Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] Artificial intelligence (AI) and big data in cancer and precision oncology
Artificial intelligence (AI) and machine learning have significantly influenced many facets of
the healthcare sector. Advancement in technology has paved the way for analysis of big …
the healthcare sector. Advancement in technology has paved the way for analysis of big …
Heterogeneity in colorectal cancer: a challenge for personalized medicine?
C Molinari, G Marisi, A Passardi, L Matteucci… - International journal of …, 2018 - mdpi.com
High inter-patient variability and high spatial heterogeneity are features of colorectal cancer
(CRC). This may influence the molecular characterization of tumor tissue, now mandatory for …
(CRC). This may influence the molecular characterization of tumor tissue, now mandatory for …
[HTML][HTML] Unravelling the complexity of colorectal cancer: Heterogeneity, clonal evolution, and clinical implications
N Saoudi González, F Salvà, J Ros, I Baraibar… - Cancers, 2023 - mdpi.com
Simple Summary Metastatic colorectal cancer is a complex, prevalent, and life-threatening
disease influenced by various factors that affect its progression, evolution, and treatment …
disease influenced by various factors that affect its progression, evolution, and treatment …
[HTML][HTML] The liquid biopsy in the management of colorectal cancer: an overview
M Vacante, R Ciuni, F Basile, A Biondi - Biomedicines, 2020 - mdpi.com
Currently, there is a crucial need for novel diagnostic and prognostic biomarkers with high
specificity and sensitivity in patients with colorectal cancer. A “liquid biopsy” is characterized …
specificity and sensitivity in patients with colorectal cancer. A “liquid biopsy” is characterized …
ALK (D5F3) CDx: an immunohistochemistry assay to identify ALK-positive NSCLC patients
H Uruga, M Mino-Kenudson - … and Personalized Medicine, 2018 - Taylor & Francis
Screening for anaplastic lymphoma kinase (ALK) rearrangements is a very important
process in treatment decision making for advanced non-small-cell lung cancer (NSCLC) …
process in treatment decision making for advanced non-small-cell lung cancer (NSCLC) …
Comprehensive tumor molecular profile analysis in clinical practice
M Özdoğan, E Papadopoulou, N Tsoulos… - BMC Medical …, 2021 - Springer
Background Tumor molecular profile analysis by Next Generation Sequencing technology is
currently widely applied in clinical practice and has enabled the detection of predictive …
currently widely applied in clinical practice and has enabled the detection of predictive …
[HTML][HTML] Clinical application of targeted deep sequencing in metastatic colorectal cancer patients: actionable genomic alteration in K-MASTER project
Y Lee, S Lee, JS Sung, HJ Chung… - … : Official Journal of …, 2021 - synapse.koreamed.org
Purpose Next-generation sequencing (NGS) can facilitate precision medicine approaches in
metastatic colorectal cancer (mCRC) patients. We investigated the molecular profiling of …
metastatic colorectal cancer (mCRC) patients. We investigated the molecular profiling of …
[HTML][HTML] Design and validation of a gene-targeted, next-generation sequencing panel for routine diagnosis in gliomas
N D'Haene, B Meléndez, O Blanchard, N De Nève… - Cancers, 2019 - mdpi.com
The updated 2016 World Health Organization (WHO) classification system for gliomas
integrates molecular alterations and histology to provide a greater diagnostic and prognostic …
integrates molecular alterations and histology to provide a greater diagnostic and prognostic …
[HTML][HTML] Development, implementation and assessment of molecular diagnostics by next generation sequencing in personalized treatment of cancer: experience of a …
J Simarro, R Murria, G Pérez-Simó, M Llop… - Cancers, 2019 - mdpi.com
The establishment of precision medicine in cancer patients requires the study of several
biomarkers. Single-gene testing approaches are limited by sample availability and …
biomarkers. Single-gene testing approaches are limited by sample availability and …
MicroRNA-128 targeting RPN2 inhibits cell proliferation and migration through the Akt-p53-cyclin pathway in colorectal cancer cells
T Zhou, L Wu, Q Wang, Z Jiang, Y Li… - Oncology …, 2018 - spandidos-publications.com
Colorectal cancer (CRC) is a malignancy with high metastatic rates. The mechanism of miR-
128 on the regulation of Ribophorin-II (RPN2) in CRC cells was explored in the present …
128 on the regulation of Ribophorin-II (RPN2) in CRC cells was explored in the present …